Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): WO/2013/176772
Who filed: Oscar Lizarazo (Plebio Research Group)
Country: Colombia
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 26-06-2015
Patent type: Other

Click within the document, or manually enter the page number below

Mylan Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (1732/MUMNP/2009)

Countries: India Date: 2013
Matrix Laboratories Ltd & Indian Network of People Living with HIV/AIDS (INP+) opposition, atazanavir (ATV) , (310/CHE/2007 (Divisional of 805/MAS/1997))

Countries: India Date: 2013
Delhi Network of Positive People (DNP+) opposition, Dolutegravir, (3865/KOLNP/2007)

Countries: India Date: 2013
Network of Maharashtra People Living with HIV (NMP+) opposition, Bedaquiline, (1220/MUMNP/2009 (WO2008068231))

Countries: India Date: 2013
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir (GS7977) , (3658/KOLNP/2009)

Countries: India Date: 2013
Fundación GEP and Red Argentina de Personas Positivas opposition, tenofovir disoproxil fumarate/emtricitabine/efavirenz (TDF/FTC/EFV) , (AR 054060 A1)

Countries: Argentina Date: 2013
Delhi Network of Positive People (DNP+) opposition, raltegravir (RAL) , (4187/DELNP/2007)

Countries: India Date: 2013
Mylan Laboratories Ltd. opposition, lopinavir/ritonavir (LPV/r) , (6733/DELNP/2007)

Countries: India Date: 2013
BDR Pharmaceuticals Ltd. opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))

Countries: India Date: 2013
BDR Pharmaceuticals Ltd. opposition, Dasatinib , (4309/DELNP/2006)

Countries: India Date: 2013

Oscar Lizarazo (Plebio Research Group) Opposition, Crispr/Cas9, (Wo/2013/176772 )